Syneron Medical Ltd (Nasdaq: ELOS) announced that its proprietary Sublative™ technology has received CE Mark indication for the effective treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE